费森尤斯医疗(FMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FMS 费森尤斯医疗

交易中 04-30 10:27:14 EDT

22.47

+0.31

+1.40%

最高22.47	最低22.29	成交量5.03万
今开22.36	昨收22.16	日振幅0.80%
总市值131.90亿	流通市值93.83亿	总股本5.87亿
成交额112.43万	换手率0.01%	流通股本4.18亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FMS","market":"US","secType":"STK","nameCN":"费森尤斯医疗","latestPrice":22.47,"timestamp":1777559221240,"preClose":22.16,"halted":0,"volume":50264,"delay":0,"changeRate":0.013989169675090195,"floatShares":417595667,"shares":587000000,"eps":1.971718,"marketStatus":"交易中","change":0.31,"latestTime":"04-30 10:27:14 EDT","open":22.355,"high":22.47,"low":22.292,"amount":1124268.057168,"amplitude":0.008032,"askPrice":22.48,"askSize":1124,"bidPrice":22.46,"bidSize":304,"shortable":3,"etf":0,"ttmEps":1.971718,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777579200000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":842932800000,"exchange":"NYSE","adjPreClose":22.16,"dividendRate":0.037548,"preHourTrading":{"tag":"盘前","latestPrice":22.36,"preClose":22.16,"latestTime":"09:29 EDT","volume":3618,"amount":80627.32899,"timestamp":1777555798367,"change":0.2,"changeRate":0.009025,"amplitude":0.013989},"postHourTrading":{"tag":"盘后","latestPrice":22.16,"preClose":22.16,"latestTime":"16:51 EDT","volume":5517,"amount":122256.34,"timestamp":1777495860519,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.831227,"impliedVol":0.4062,"impliedVolPercentile":0.7251},"requestUrl":"/m/hq/s/FMS","defaultTab":"news","newsList":[{"id":"1133202254","title":"财报前瞻｜费森尤斯医疗本季度营收预计下滑5.09%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1133202254","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133202254?lang=zh_cn&edition=full","pubTime":"2026-04-28 10:22","pubTimestamp":1777342968,"startTime":"0","endTime":"0","summary":"费森尤斯医疗将于2026年05月05日发布最新季度财报，市场关注利润率修复与费用效率的延续表现。综合近期的前瞻报道与机构跟踪情况，观点整体偏多。2026年02月17日的前瞻信息指出，在营收可能小幅下行的预期下，利润率改善与费用效率变化成为一致预期的核心看点，这与上一季度息税前利润同比增长44.17%与调整后每股收益同比增长58.24%的实际表现相呼应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜费森尤斯医疗本季度营收预计下滑5.09%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614816338","title":"费森尤斯医疗2025财年实现净利润11.04亿美元，同比增加89.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614816338","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614816338?lang=zh_cn&edition=full","pubTime":"2026-02-28 00:00","pubTimestamp":1772208036,"startTime":"0","endTime":"0","summary":"2月28日，费森尤斯医疗公布财报，公告显示公司2025财年净利润为11.04亿美元，同比增加89.69%；其中营业收入为221.62亿美元，同比增加5.95%，每股基本收益为1.90美元。机构评级：截至2026年2月28日，当前有16家机构对费森尤斯医疗目标价做出预测，其中目标均价为25.78美元，其中最低目标价为18.88美元，最高目标价为36.12美元。公司简介：费森尤斯医疗是世界上最大的透析公司，截至2024年12月，在全球近3700家诊所治疗约30万名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228000051a72771fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228000051a72771fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148732335","title":"财报前瞻｜费森尤斯医疗本季度营收预计小幅下滑，利润率改善成关键看点","url":"https://stock-news.laohu8.com/highlight/detail?id=1148732335","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148732335?lang=zh_cn&edition=full","pubTime":"2026-02-17 10:41","pubTimestamp":1771296089,"startTime":"0","endTime":"0","summary":"费森尤斯医疗将于2026年2月24日美股盘前发布最新季度业绩，市场普遍关注在营收持平略降背景下的利润率改善与费用效率变化。本季度一致预期显示营收同比小幅下行，但利润端上修，侧面反映服务板块的效率有望进一步改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜费森尤斯医疗本季度营收预计小幅下滑，利润率改善成关键看点","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592163488","title":"2026年HBM市场的关键：HBM4","url":"https://stock-news.laohu8.com/highlight/detail?id=2592163488","media":"半导体产业纵横","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592163488?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:21","pubTimestamp":1766139670,"startTime":"0","endTime":"0","summary":"SK海力士计划在2026年前大幅提升HBM产能首先，来看一下供应趋势。2026年，搭载 HBM4 世代模块的 AI 加速芯片将正式量产出货。到2025年，HBM单位存储容量的价格将上涨21%平均售价是指HBM模块每千兆比特的价格。HBM价格谈判每年进行一次。2022年的平均售价为1.40美元，2023年略微下降至1.38美元，2024年回升至1.49美元。该年的价格上涨归因于HBM3E一代产品出货率的提高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219182318a6b6ba72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219182318a6b6ba72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0082616367.USD","BK4023","BK4528","LU2211815571.USD","NVDA","LU2355687059.USD","LU0081259029.USD","LU0157215616.USD","BK4512","LU1951198990.SGD","LU0979878070.USD","BK4529","BK4554","BK4575","BK4612","LU1852331112.SGD","LU0127658192.USD","LU2089985449.USD","IE00B7SZLL34.SGD","LU0056508442.USD","BK4532","LU0823434583.USD","IE00BMPRXN33.USD","BK4551","LU1303367103.USD","LU0109392836.USD","LU0198837287.USD","LU0203345920.USD","AI","LU0642271901.SGD","BK4141","BK4168","FMS","MU","HBM","LU2458330169.SGD","LU0203347892.USD","LU0823434740.USD","BK4566","BK4579","LU1242518931.SGD","BK4553","LU1316542783.SGD","AMD","LU1366333091.USD","LU2048586759.USD","IE00B19Z3B42.SGD","LU0823421416.USD","IE00B19Z3581.USD","BK4543","LU2098885051.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2583669888","title":"豁免政策没了，韩国买美国武器还得多花钱","url":"https://stock-news.laohu8.com/highlight/detail?id=2583669888","media":"观察者网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583669888?lang=zh_cn&edition=full","pubTime":"2025-11-16 15:00","pubTimestamp":1763276400,"startTime":"0","endTime":"0","summary":"　　分析指出，在韩国承诺购买更多美国武器之际，此举无疑将增加韩国的财政负担。　　消息人士指出，此前的豁免政策为韩国采购美国武器节省了5%左右的费用，随着豁免政策取消，韩方引进美国武器的成本负担将加重。　　11月14日，韩国总统李在明在首尔龙山总统府举行新闻发布会，宣布韩美敲定两国关税和国家安全磋商成果文件“联合事实清单”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-16/doc-infxqqtk4781579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4213","BK4196","FMS","GDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516072567","title":"美敦力、强生、雅培、西门子医疗、费森尤斯医疗、飞利浦等27大全球医疗器械和诊断企业2024年第四季度和全年财报汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=2516072567","media":"全球企业动态","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516072567?lang=zh_cn&edition=full","pubTime":"2025-03-02 07:11","pubTimestamp":1740870660,"startTime":"0","endTime":"0","summary":"美敦力公布截至2025年1月25日的第三财季业绩。医疗器械及设备制造商史赛克公布2024年第四季度和全年业绩。西门子医疗公布截至2024年12月31日的财年第一财季业绩。第四季度总营收53.19亿美元，上年同期为52.06亿美元。季度调整后的EBITDA利润9.05亿欧元，上年同期为8.96亿欧元。全年归属公司股东的净利润82.77亿瑞士法郎，上年为114.98亿瑞士法郎，同比下降28%。诊断业务全年销售额143.24亿瑞士法郎，营业利润19.46亿瑞士法郎。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-03-02/doc-inenfmis8028388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","159891","JNJ","MDT","09997","SIEGY","ABT","FMS","PHG","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516552246","title":"费森尤斯医疗2024财年实现净利润5.82亿美元，同比增加7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552246?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844852,"startTime":"0","endTime":"0","summary":"3月2日，费森尤斯医疗公布财报，公告显示公司2024财年净利润为5.82亿美元，同比增加7.98%；其中营业收入为209.17亿美元，同比减少0.55%，每股基本收益为0.99美元。从资产负债表来看，费森尤斯医疗总负债184.30亿美元，其中短期债务12.62亿美元，资产负债比为1.89，流动比率为1.39。机构评级：截至2025年3月2日，当前有18家机构对费森尤斯医疗目标价做出预测，其中目标均价为24.43美元，其中最低目标价为17.32美元，最高目标价为29.16美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000106abe2c57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000106abe2c57e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514099121","title":"Fresenius Medical Care(FMS.US)：2024年Q4财报实现营收54.27亿美元，前值为53.69亿美元，预期值为55.4亿美元；每股收益为0.49美元，前值为0.47美元，预期值为0.40美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099121","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514099121?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:11","pubTimestamp":1740489110,"startTime":"0","endTime":"0","summary":"Fresenius Medical Care(FMS.US)：2024年Q4财报实现营收54.27亿美元，前值为53.69亿美元，预期值为55.4亿美元；每股收益为0.49美元，前值为0.47美元，预期值为0.40美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25211148383090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154057062","title":"费森尤斯医疗护理2024年第四季度调整后每股收益€0.91 超出预期€0.86，销售额€50.8亿 超出预期€47.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1154057062","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154057062?lang=zh_cn&edition=full","pubTime":"2025-02-25 17:56","pubTimestamp":1740477374,"startTime":"0","endTime":"0","summary":"费森尤斯医疗护理报告季度每股收益0.91，超出分析师共识预期的0.86，超出幅度为5.81%。相比去年同期每股收益0.52，同比增加了75%。公司报告季度销售额为50.8亿，超出分析师共识预期的47.5亿，超出幅度为7.12%。以上内容来自Benzinga Earnings专栏，原文如下：Fresenius Medical Care  reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.86 by 5.81 percent. This is a 75 percent increase over earnings of $0.52 per share from the same period last year.  The company reported quarterly sales of $5.08 billion which beat the analyst consensus estimate of $4.75 billion by 7.12","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"费森尤斯医疗护理2024年第四季度调整后每股收益€0.91 超出预期€0.86，销售额€50.8亿 超出预期€47.5亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506682906","title":"3187亿美元！美国2024年对外军售再创新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2506682906","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506682906?lang=zh_cn&edition=full","pubTime":"2025-01-25 16:45","pubTimestamp":1737794726,"startTime":"0","endTime":"0","summary":"财联社1月25日讯 当地时间周五，美国国务院表示，2024年美国对外国政府的军事装备销售额同比飙升29%，达到创纪录的3187亿美元。美国国务院发布声明称，武器销售和转让被视为重要的美国外交政策工具，对地区和全球安全有着潜在的长期影响。在欧盟中波兰是美国军事装备的最大买家，与美国军工企业签订了600多亿美元的订单。波兰也是欧洲扩军备战最积极的国家，今年已拨出创纪录的464亿美元用于国防，占经济产出的4.7%，高于去年的3.5%。","market":"us","thumbnail":"http://n.sinaimg.cn/default/feedbackpics/transform/116/w550h366/20180418/ubGb-fzihnep5208613.png","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/default/feedbackpics/transform/116/w550h366/20180418/ubGb-fzihnep5208613.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-25/doc-inehesia0999034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["FMS","BK4213","GDP","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045527","title":"费森尤斯医疗盘中异动 临近午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505045527?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:31","pubTimestamp":1737649901,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时31分，费森尤斯医疗股票出现波动，股价急速上涨5.09%。截至发稿，该股报24.35美元/股，成交量10.9047万股，换手率0.02%，振幅0.86%。费森尤斯医疗股票所在的医疗设施行业中，整体涨幅为1.20%。费森尤斯医疗公司简介：Fresenius Medical Care 是世界上最大的透析公司，截至2024年年中，在全球约3750家诊所治疗超过30万名患者。Fresenius 占全球透析产品市场约35%的份额，并受益于其是全球唯一一家完全整合的透析企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003141a22d22df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003141a22d22df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486538211","title":"美敦力、强生、GE医疗、西门子医疗、费森尤斯医疗、飞利浦等28大全球医疗器械和诊断企业2024年第三季度财报汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=2486538211","media":"全球企业动态","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486538211?lang=zh_cn&edition=full","pubTime":"2024-11-28 06:47","pubTimestamp":1732747620,"startTime":"0","endTime":"0","summary":"美敦力公布截至2024年10月25日的第二财季业绩。诊断业务销售额为24.12亿美元，同比下降1.5%。西门子医疗公布截至2024年9月30日的第四财季和财年业绩。调整后的EBIT利润11.2亿欧元，上年同期为10.45亿欧元，同比增长7%。医疗器械及设备制造商史赛克公布2024年第三季度业绩。季度归属公司的净利润4.16亿美元，上年同期净亏损1200万美元。季度净亏损1280万美元，上年同期净亏损640万美元。舒万诺公布2024年第三季度业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-11-28/doc-incxqkks6087737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","MDT","159891","09996","JNJ","159883","FMS","GE","PHG","SIEGY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482522709","title":"【经观讲堂第35期】武文强：如何健康、科学地长跑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2482522709","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482522709?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:28","pubTimestamp":1731414480,"startTime":"0","endTime":"0","summary":"如今，颈前伸、脊柱侧弯等姿势问题在中小学生群体中的出现比例逐年升高，已经引起家长和教育部门的关注。若出现高低肩、高低髋、颈前伸、骨盆前倾、脊柱侧弯等问题，跑者应进行专业的康复和纠正。FMS测试通过七个基础动作评估主要关节的力量、活动度和稳定性，找出运动中可能存在的薄弱环节，再进行针对性的改善训练。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2024-11-12/doc-incvvkhh8780888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4196","FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482267889","title":"费森尤斯医疗2024财年第三财季实现净利润2.34亿美元，同比增加155.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482267889?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254428,"startTime":"0","endTime":"0","summary":"11月11日，费森尤斯医疗公布财报，公告显示公司2024财年第三财季净利润为2.34亿美元，同比增加155.01%；其中营业收入为52.29亿美元，同比减少2.63%，每股基本收益为0.40美元。机构评级：截至2024年11月11日，当前有17家机构对费森尤斯医疗目标价做出预测，其中目标均价为21.34美元，其中最低目标价为15.81美元，最高目标价为27.25美元。Fresenius 占全球透析产品市场约35%的份额，并受益于其是全球唯一一家完全整合的透析企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479782048","title":"费森尤斯医疗盘中异动 早盘快速下挫5.00%报19.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479782048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479782048?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:52","pubTimestamp":1730299927,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时52分，费森尤斯医疗股票出现波动，股价快速下挫5.00%。截至发稿，该股报19.37美元/股，成交量22.5733万股，换手率0.04%，振幅1.32%。费森尤斯医疗股票所在的医疗设施行业中，整体跌幅为1.42%。费森尤斯医疗公司简介：Fresenius Medical Care 是世界上最大的透析公司，截至2024年年中，在全球约3750家诊所治疗超过30万名患者。Fresenius 占全球透析产品市场约35%的份额，并受益于其是全球唯一一家完全整合的透析企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030225207971a343b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030225207971a343b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2466418042","title":"强生、美敦力、西门子医疗、费森尤斯医疗、飞利浦、GE医疗等28大全球医疗器械和诊断企业2024年第二季度财报汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=2466418042","media":"全球企业动态","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466418042?lang=zh_cn&edition=full","pubTime":"2024-09-11 06:31","pubTimestamp":1726007460,"startTime":"0","endTime":"0","summary":"美敦力公布截至2024年7月26日的第一财季业绩。诊断业务营收为21.95亿美元，同比下降5.3%。碧迪公布截至2024年6月30日的第三季度业绩。GE医疗公布2024年第二季度业绩。第四财季营收598.67亿美元，归属公司净利润2.35亿美元。其中，医疗产品和分销业务第四财季营收31亿美元，利润4700万美元。季度净亏损3191万美元，上年同期净亏损2824万美元。季度归属于母公司所有者的净利润338.91亿日元，上年同期为225.49亿日元，同比增长50.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-09-11/doc-incntriy7594805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["JNJ","FMS","159891","SIEGY","159883","MDT","09996","PHG","GE","09997"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.freseniusmedicalcare.com","stockEarnings":[{"period":"1week","weight":-0.0306},{"period":"1month","weight":-0.0023},{"period":"3month","weight":-0.016},{"period":"6month","weight":-0.1744},{"period":"1year","weight":-0.1129},{"period":"ytd","weight":-0.0697}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.126},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0433},{"period":"1year","weight":0.2837},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fresenius Medical Care AG最初于1996年8月5日成立为股份公司，并于2006年2月10日注册成为股份有限公司。该公司是世界领先的肾病患者产品和服务提供商。作为一家垂直整合的医疗技术（MedTech）和医疗服务公司，费森尤斯医疗将医疗器械工程和制造专业知识与全面的患者护理相结合。在三个运营部门，即护理交付（CD）、基于价值的护理（VBC）和护理支持（CE），公司提供全方位的医疗服务、系统、设备、技术、产品和药品，为全球肾病患者提供高质量的护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.013378},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.006573},{"month":3,"riseRate":0.666667,"avgChangeRate":0.014273},{"month":4,"riseRate":0.633333,"avgChangeRate":0.023719},{"month":5,"riseRate":0.344828,"avgChangeRate":-0.013329},{"month":6,"riseRate":0.724138,"avgChangeRate":0.010145},{"month":7,"riseRate":0.586207,"avgChangeRate":-0.007859},{"month":8,"riseRate":0.448276,"avgChangeRate":-0.023864},{"month":9,"riseRate":0.551724,"avgChangeRate":-0.00021},{"month":10,"riseRate":0.433333,"avgChangeRate":-0.007561},{"month":11,"riseRate":0.7,"avgChangeRate":0.05118},{"month":12,"riseRate":0.566667,"avgChangeRate":0.010648}],"exchange":"NYSE","name":"费森尤斯医疗","nameEN":"Fresenius Medical Care AG & Co. KGaA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"费森尤斯医疗(FMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供费森尤斯医疗(FMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"费森尤斯医疗,FMS,费森尤斯医疗股票,费森尤斯医疗股票老虎,费森尤斯医疗股票老虎国际,费森尤斯医疗行情,费森尤斯医疗股票行情,费森尤斯医疗股价,费森尤斯医疗股市,费森尤斯医疗股票价格,费森尤斯医疗股票交易,费森尤斯医疗股票购买,费森尤斯医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"费森尤斯医疗(FMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供费森尤斯医疗(FMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}